A 4-microRNA Signature in Serum Can Discriminate Between Non-Small-Cell Lung Cancer and Malignant Pleural Mesothelioma

被引：0
|
作者：
Kirschner, M. [1 ]
Leygo, C. [2 ]
Burgers, S. [3 ]
Korse, T. [3 ]
Van Den Broek, D. [3 ]
Van Zandwijk, N. [2 ]
Reid, G. [2 ]
机构：
[1] Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland
[2] Asbestos Dis Res Inst, Sydney, NSW, Australia
[3] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
MicroRNAs; NSCLC; Mesothelioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.09-008
引用
收藏
页码：S2019 / S2020
页数：2
相关论文
共 50 条
  • [1] Vandetanib and Indwelling Pleural Catheter for Non-Small-Cell Lung Cancer With Recurrent Malignant Pleural Effusion
    Massarelli, Erminia
    Onn, Amir
    Marom, Edith M.
    Alden, Christine M.
    Liu, Diane D.
    Tran, Hai T.
    Mino, Barbara
    Wistuba, Ignacio I.
    Faiz, Saadia A.
    Bashoura, Lara
    Eapen, George A.
    Morice, Rodolfo C.
    Lee, J. Jack
    Hong, Waun K.
    Herbst, Roy S.
    Jimenez, Carlos A.
    CLINICAL LUNG CANCER, 2014, 15 (05) : 379 - 386
  • [2] A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears
    Fassina, Ambrogio
    Cappellesso, Rocco
    Simonato, Francesca
    Siri, Maayan
    Ventura, Laura
    Tosato, Francesca
    Busund, Lill-Tove
    Pelizzo, Maria Rosa
    Fassan, Matteo
    CANCER CYTOPATHOLOGY, 2014, 122 (04) : 274 - 281
  • [3] Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
    Zhu, Xinping
    Kudo, Masahisa
    Huang, Xiangjie
    Sui, Hehuan
    Tian, Haishan
    Croce, Carlo M.
    Cui, Ri
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [4] NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer
    Leal, Jose Luis
    Peters, Geoffrey
    Szaumkessel, Marcin
    Leong, Trishe
    Asadi, Khashayar
    Rivalland, Gareth
    Do, Hongdo
    Senko, Clare
    Mitchell, Paul L.
    Quing, Chai Zi
    Dobrovic, Alexander
    Thapa, Bibhusal
    John, Thomas
    LUNG CANCER, 2020, 146 : 154 - 159
  • [5] Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more
    Chen, Dawei
    Song, Xinyu
    Zhang, Yan
    Kong, Li
    Wang, Haiyong
    Yu, Jinming
    FUTURE ONCOLOGY, 2018, 14 (21) : 2131 - 2138
  • [6] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    ONKOLOGE, 2021, 27 (02): : 179 - 190
  • [7] Cancer vaccines for non-small-cell lung cancer
    Palma, M.
    Choudhury, A.
    Mellstedt, H.
    MINERVA CHIRURGICA, 2009, 64 (06) : 643 - 653
  • [8] Erlotinib in non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Malone, Paolo
    Colantuoni, Giuseppe
    Del Gaizo, Filomena
    Ferrara, Carmine
    Nicolella, Dario
    Guerriero, Ciro
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2579 - 2592
  • [9] Cetuximab in non-small-cell lung cancer
    Carillio, Guido
    Montanino, Agnese
    Costanzo, Raffaele
    Sandomenico, Claudia
    Piccirillo, Maria Carmela
    Di Maio, Massimo
    Daniele, Gennaro
    Giordano, Pasqualina
    Bryce, Jane
    Normanno, Nicola
    Rocco, Gaetano
    Perrone, Francesco
    Morabito, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 163 - 175
  • [10] Non-small-cell lung cancer in the elderly
    Meriggi, F
    Zaniboni, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (02) : 183 - 190
12345